Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Bosentan in Children With Pulmonary Arterial Hypertension Extension Study (FUTURE 2)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Actelion
ClinicalTrials.gov Identifier:
NCT00319020
First received: April 26, 2006
Last updated: June 2, 2016
Last verified: June 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: October 2011
  Primary Completion Date: October 2011 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Received: March 9, 2012
Publications: